Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

DNA copy number changes in diffuse large B-cell lymphoma--comparative genomic hybridization study

O Monni1, H Joensuu, K Franssila

  • 1Department of Medical Genetics, Haartman Institute, University of Helsinki, Finland.

Blood
|June 15, 1996
PubMed
Summary

This study reveals frequent DNA copy number changes in diffuse large B-cell lymphoma, with recurrent tumors showing more aberrations than primary ones. Novel high-level amplifications, including BCL2 gene amplification, were identified.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Safety, pharmacokinetics, pharmacodynamics, and antitumor activity of cergutuzumab amunaleukin: a phase I study in patients with advanced and/or metastatic solid tumors.

ESMO open·2026
Same author

Including tumor-infiltrating lymphocytes into the PREDICT prognostic model for triple-negative breast cancer survival.

Annals of oncology : official journal of the European Society for Medical Oncology·2026
Same author

Gastrointestinal stromal tumours: ESMO-EURACAN-GENTURIS Clinical Practice Guidelines for diagnosis, treatment and follow-up.

Annals of oncology : official journal of the European Society for Medical Oncology·2021
Same author

Bone sarcomas: ESMO-EURACAN-GENTURIS-ERN PaedCan Clinical Practice Guideline for diagnosis, treatment and follow-up.

Annals of oncology : official journal of the European Society for Medical Oncology·2021
Same author

Soft tissue and visceral sarcomas: ESMO-EURACAN-GENTURIS Clinical Practice Guidelines for diagnosis, treatment and follow-up<sup>☆</sup>.

Annals of oncology : official journal of the European Society for Medical Oncology·2021
Same author

Benefit of pazopanib in advanced gastrointestinal stromal tumours: results from a phase II trial (SSG XXI, PAGIST).

ESMO open·2021

Area of Science:

  • Oncology
  • Genetics
  • Molecular Biology

Background:

  • Diffuse large B-cell lymphoma (DLBCL) is a heterogeneous hematologic malignancy.
  • Understanding genetic alterations is crucial for diagnosing and treating DLBCL.
  • Comparative genomic hybridization (CGH) is a valuable tool for detecting DNA copy number variations.

Purpose of the Study:

  • To investigate DNA copy number alterations in primary and recurrent diffuse large B-cell lymphoma.
  • To identify frequently gained and lost chromosomal regions.
  • To characterize novel high-level amplifications and their potential role in BCL2 overexpression.

Main Methods:

  • Comparative genomic hybridization (CGH) analysis was performed on 20 primary and 12 recurrent DLBCL tumors.
  • Southern blot analysis was used to confirm BCL2 amplification.

Related Experiment Videos

  • Statistical analysis was employed to compare aberration frequencies between primary and recurrent tumors.

    • Main Results:

    • 91% of DLBCL cases exhibited abnormal copy number karyotypes.
    • Frequent gains were observed on chromosomes X, 1q, 7, 3, 6p, 11, 12, and 18.
    • Recurrent tumors displayed a higher median number of aberrations (6.5) compared to primary tumors (2).
    • Novel high-level amplifications were detected, including at 18q21-ter, suggesting BCL2 gene amplification as a mechanism for overexpression.

    Conclusions:

    • DNA copy number changes are prevalent in DLBCL and increase in recurrent disease.
    • Specific chromosomal regions are recurrently altered, providing potential targets for further research.
    • Gene amplification, particularly of BCL2, represents an alternative mechanism to translocation for BCL2 protein overexpression in DLBCL.